Home
Profile
Awards
Key Products
Products
Media Partners Careers Contacts
Consumer
Medical
Intact Pharma
Intact Pharma
History
Vision, Mission & Core Values
Manufacturing Facilities
Group of Companies
Ellgy plus
Ezerra
T3
SEARCH 
INTACT PHARMA
-
ANTIEMETIC
-
ANTIHISTAMINES
-
CORTICOSTEROIDS, ORAL
-
COUGH & COLD PREPARATIONS
-
DRUGS USED IN SUBSTANCE DEPENDENCE
-
EZERRA
-
URINARY ALKALINIZER
Product 4 INTACT PHARMA4CORTICOSTEROIDS, ORAL
CORTICOSTEROIDS, ORAL


Zoralone Syrup
Description

Each 5 ml contains 3 mg Prednisolone in a clear straw–coloured syrupy liquid with a raspberry flavour.

Indications

Conditions in which routine systemic corticosteroid therapy is indicated, except adrenal-deficiency states for which lack of sodium-retaining properties makes it less suitable. Examples of conditions in which systemic corticosteroid therapy is indicated include bronchial asthma, allergic disorders, rheumatic fever, rheumatoid arthritis, and inflammatory skin diseases.

Dosage

The following is intended as a guide only. Dosage should be modified in relation to the therapeutic response and evolution of the disease.
Non – endocrine disorders in children: 0.5 to 2 mg per kg daily of prednisolone in 3 or 4 divided doses, after meals. Maximum daily dose rarely exceeds 400 mg.

Presentation

60 ml plastic bottle.


Copyright 2018 © HOE Pharmaceuticals. All Rights Reserved.